CLEVELAND, Sept. 8 /PRNewswire-FirstCall/ -- Cleveland BioLabs, Inc. (NASDAQ:CBLI)(Boston Stock Exchange:CFB), today announced that it has retained The Global Consulting Group as the Company's strategic investor relations counsel.

Michael Fonstein, Ph.D., Chief Executive Officer of Cleveland BioLabs, said, "We selected The Global Consulting Group based on its reputation and proven track record of enhancing shareholder value for clients. Their extensive healthcare experience will be invaluable as we move forward following our IPO. We are committed to maintaining an open and proactive dialogue with the market."

Mr. Richard Wolff, Chief Executive Officer of The Global Consulting Group commented, "We are excited to work with Cleveland BioLabs to increase the company's exposure to key constituents within the financial community and the healthcare sector. We look forward to implementing a strategic communications program that effectively communicates the Company's business strategy and growth opportunities."

About Cleveland BioLabs, Inc.

Cleveland BioLabs, Inc. is a drug discovery and development company with the goal to identify and develop new types of drugs for the protection of normal tissues from exposure to radiation and other stresses and for cancer treatment. Our development efforts are based on discoveries made in connection with the investigation of the cell-level process known as apoptosis. To learn more about Cleveland BioLabs Inc., please visit the company's website at http://www.cbiolabs.com.

This press release contains forward-looking statements that reflect our current view with respect to various aspects of the events described above. Actual results could be significantly different. Factors that could affect results include those set forth in filings made by Cleveland BioLabs, Inc. with the Securities and Exchange Commission. These factors include, but are not limited to, those discussed in our Registration Statement on Form SB-2 under the caption "Risk Factors." We caution readers not to place undue reliance on these forward-looking statements. Although forward-looking statements help provide complete information about future prospects, readers should keep in mind that forward-looking statements are much less reliable than historical information.

Cleveland BioLabs, Inc.